Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: Centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points Conference

Mehta, MP, Shapiro, WR, Glantz, MJ et al. (2002). Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: Centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points . JOURNAL OF CLINICAL ONCOLOGY, 20(16), 3445-3453. 10.1200/JCO.2002.07.500

Industry Collaboration International Collaboration

cited authors

  • Mehta, MP; Shapiro, WR; Glantz, MJ; Patchell, RA; Weitzner, MA; Meyers, CA; Schultz, CJ; Roa, WH; Leibenhaut, M; Ford, J; Curran, W; Phan, S; Smith, JA; Miller, RA; Renschler, MF

sustainable development goals

authors

date/time interval

  • October 21, 2000 -

publication date

  • August 15, 2002

published in

keywords

  • FUNCTIONAL ASSESSMENT
  • Life Sciences & Biomedicine
  • ONCOLOGY
  • OXYGEN
  • Oncology
  • PARTITIONING ANALYSIS RPA
  • PROGNOSTIC-FACTORS
  • Science & Technology
  • TEXAPHYRIN

Location

  • MA, BOSTON

Digital Object Identifier (DOI)

Conference

  • 42nd Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology (ASTRO)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 3445

end page

  • 3453

volume

  • 20

issue

  • 16